Under the agreement, Stopler will have the exclusive rights to sell and distribute Z-Medica’s full line of QuikClot hemostatic agents to hospitals and healthcare professionals in The Netherlands.
QuikClot is a surgical gauze impregnated with kaolin, an inert mineral with no known contraindications, and achieves hemostasis in severe bleeding situations in three minutes.
QuikClot is used throughout several clinical specialties, including cardiology, interventional radiology, critical care, dermatology, emergency medicine, orthopedics and OB/Gyn.
Z-Medica CEO Brian Herrman said that Z-Medica is aiming to reach beyond the US borders with gauze products that are proven effective in some of the most traumatic of circumstances and are proud to work with partners like Stopler, who see the need to have QuikClot in every hospital and carried by all healthcare professionals.
